Romosozumab followed by denosumab versus denosumab only: a post hoc analysis of FRAME and FRAME extension
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Bone and Mineral Research"
DOI: 10.1093/jbmr/zjae116
Abstract: Abstract Osteoanabolic-first treatment sequences are superior to oral bisphosphonates for fracture reduction and bone mineral density (BMD) gain. However, data comparing osteoanabolic medications, with the more potent antiresorptive, denosumab (DMAb), are limited. We analyzed FRAME… read more here.
Keywords: dmab dmab; romo dmab; frame extension; dmab ... See more keywords